' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID


Gewähltes Keyword: Stem cell therapy

Regenerative Cardiovascular Therapies: Stem Cells and Beyond.
Wernly, B; Mirna, M; Rezar, R; Prodinger, C; Jung, C; Podesser, BK; Kiss, A; Hoppe, UC; Lichtenauer, M;
Int J Mol Sci. 2019; 20(6):
Current and Future Perspectives of Stem Cell Therapy in Dermatology.
Prodinger, CM; Reichelt, J; Bauer, JW; Laimer, M;
Ann Dermatol. 2017; 29(6):-687
Differences in Stem Cell Processing Lead to Distinct Secretomes Secretion-Implications for Differential Results of Previous Clinical Trials of Stem Cell Therapy for Myocardial Infarction.
Wernly, B; Gonçalves, I; Kiss, A; Paar, V; Mösenlechner, T; Leisch, M; Santer, D; Motloch, L; Klein, KU; Tretter, EV; Kretzschmar, D; Podesser, B; Jung, C; Hoppe, UC; Lichtenauer, M;
Biotechnol J. 2017; 12(9):
Originalarbeiten (Zeitschrift)
Analysis of Ambient Influences Affecting Interleukin-6 Secretion in the Context of Clinical Trials of Stem Cell Therapy for Myocardial Infarction
Edlinger, C; Wernly, B; Leisch, M; Kammler, J; Kypta, A; Eder, S; Jung, C; Hoppe, UC; Lichtenauer, M
CLIN LAB. 2016; 62(6): 1061-1068.
Originalarbeiten (Zeitschrift)
Stem Cell Therapy for Myocardial Infarction 2001-2013 Revisited.
Edlinger, C; Schreiber, C; Wernly, B; Anker, A; Ruzicka, K; Jung, C; Hoppe, UC; Lichtenauer, M;
Stem Cell Rev. 2015; 11(5):743-751
Originalarbeiten (Zeitschrift)
An accelerated mouse model for atherosclerosis and adipose tissue inflammation.
Neuhofer, A; Wernly, B; Leitner, L; Sarabi, A; Sommer, NG; Staffler, G; Zeyda, M; Stulnig, TM;
Cardiovasc Diabetol. 2014; 13: 23
Originalarbeiten (Zeitschrift)
Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment.
Dubsky, M; Jirkovska, A; Bem, R; Fejfarova, V; Pagacova, L; Sixta, B; Varga, M; Langkramer, S; Sykova, E; Jude, EB;
Diabetes Metab Res Rev. 2013; 29(5):369-376
Originalarbeiten (Zeitschrift)
The remyelination Philosopher"s Stone: stem and progenitor cell therapies for multiple sclerosis.
Jadasz, JJ; Aigner, L; Rivera, FJ; Küry, P;
Cell Tissue Res. 2012; 349(1):331-347
Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis.
Rivera, FJ; Aigner, L;
Biol Res. 2012; 45(3):257-268
[Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells].
Dubský, M; Jirkovská, A; Bém, R; Pagácová, L; Fejfarová, V; Varga, M; Skibová, J; Langkramer, S; Syková, E;
Vnitr Lek. 2011; 57(5):451-455
Originalarbeiten (Zeitschrift)
Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D;
CYTOTHERAPY. 2011; 13(4): 503-512.
Originalarbeiten (Zeitschrift)
Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy.
Strunk, D; Rohde, E; Lanzer, G; Linkesch, W
Transfusion. 2005; 45(3):315-326
Originalarbeiten (Zeitschrift)